Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients

Objective: To reduce the risk of locoregional recurrence, the addition of neoadjuvant concurrent chemoradiotherapy (CCRT) is recommended before surgical management for rectal cancer patients. However, despite identical tumor histology, individual patient response to neoadjuvant CCRT varies greatly....

Descripción completa

Detalles Bibliográficos

Autores principales:	Tzu-Ju Chen, Bei-Hao Hsu, Sung-Wei Lee, Ching-Chieh Yang, Yu-Feng Tian, Yu-Hsuan Kuo, Wan-Shan Li, Hsin-Hwa Tsai, Li-Ching Wu, Cheng-Fa Yeh, Chia-Lin Chou, Hong-Yue Lai
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2022-10-01
Colección:	Pathology and Oncology Research
Materias:	biomarker rectal cancer DHRS9 epithelial cell differentiation keratan sulfate mucin
Acceso en línea:	https://www.por-journal.com/articles/10.3389/pore.2022.1610537/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!